2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children with Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening...

Overview

Journal Arthritis Care Res (Hoboken)

Specialty Rheumatology

Date 2013 Oct 1

PMID 24078300

Citations 33

Authors

Sarah Ringold

Pamela F Weiss

Timothy Beukelman

Esi Morgan DeWitt

Norman T Ilowite

Yukiko Kimura

Ronald M Laxer

Daniel J Lovell

Peter A Nigrovic

Angela Byun Robinson

Richard K Vehe

Affiliations

Soon will be listed here.

Citing Articles

Intra-articular corticosteroid utilization and characterizations of use in juvenile idiopathic arthritis within the PR-COIN registry.

Balay-Dustrude E, Weiss J, Goh Y, Rubin N, Bullock D Front Pediatr. 2024; 12:1423362.

PMID: 39108690 PMC: 11300215. DOI: 10.3389/fped.2024.1423362.

Diagnosing and Treating Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease as Part of the Still's Disease Continuum.

Kontzias A, Petryna O, Nakasato P, Efthimiou P Mediterr J Rheumatol. 2024; 35(Suppl 1):45-57.

PMID: 38756937 PMC: 11094444. DOI: 10.31138/mjr.290323.dat.

[Protocols in pediatric rheumatology (PROKIND): treat-to-target in polyarticular juvenile idiopathic arthritis].

Horneff G, Minden K, Foell D, Klotsche J, Tenbrock K Z Rheumatol. 2023; 83(1):15-27.

PMID: 38157052 DOI: 10.1007/s00393-023-01452-0.

Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies.

Yang C, Nguyen J, Yen Y J Biomed Sci. 2023; 30(1):89.

PMID: 37864230 PMC: 10590030. DOI: 10.1186/s12929-023-00982-8.

Disability and disease-related damage in Thai children and adolescents with juvenile idiopathic arthritis.

Tangcheewinsirikul S, Sukharomana M, Charuvanij S Pediatr Rheumatol Online J. 2023; 21(1):68.

PMID: 37430274 PMC: 10332097. DOI: 10.1186/s12969-023-00852-5.

References

Kelly A, Ramanan A . A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol. 2008; 4(11):615-20. DOI: 10.1038/ncprheum0919. View

Nigrovic P, Mannion M, Prince F, Zeft A, Rabinovich C, van Rossum M . Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum. 2011; 63(2):545-55. DOI: 10.1002/art.30128. View

Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J . Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005; 201(9):1479-86. PMC: 2213182. DOI: 10.1084/jem.20050473. View

Ruperto N, Lovell D, Li T, Sztajnbok F, Goldenstein-Schainberg C, Scheinberg M . Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2010; 62(11):1542-51. DOI: 10.1002/acr.20283. View

Hedrich C, Bruck N, Fiebig B, Gahr M . Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA). Rheumatol Int. 2011; 32(11):3525-30. DOI: 10.1007/s00296-011-2249-4. View

Hadchouel M, Prieur A, Griscelli C . Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr. 1985; 106(4):561-6. DOI: 10.1016/s0022-3476(85)80072-x. View

Sawhney S, Woo P, Murray K . Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001; 85(5):421-6. PMC: 1718981. DOI: 10.1136/adc.85.5.421. View

Lanni S, Bertamino M, Consolaro A, Pistorio A, Magni-Manzoni S, Galasso R . Outcome and predicting factors of single and multiple intra-articular corticosteroid injections in children with juvenile idiopathic arthritis. Rheumatology (Oxford). 2011; 50(9):1627-34. DOI: 10.1093/rheumatology/ker165. View

Petty R, Southwood T, Manners P, Baum J, Glass D, Goldenberg J . International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31(2):390-2. View

10.

Becker M, Rose C, Cron R, Sherry D, Bilker W, Lautenbach E . Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: comparison of 2 initial dosing regimens. J Rheumatol. 2010; 37(4):870-5. PMC: 2893572. DOI: 10.3899/jrheum.090826. View

11.

Otten M, Prince F, Armbrust W, ten Cate R, Hoppenreijs E, Twilt M . Factors associated with treatment response to etanercept in juvenile idiopathic arthritis. JAMA. 2011; 306(21):2340-7. DOI: 10.1001/jama.2011.1671. View

12.

Ruperto N, Lovell D, Quartier P, Paz E, Rubio-Perez N, Silva C . Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum. 2010; 62(6):1792-802. DOI: 10.1002/art.27431. View

13.

Ravelli A, De Benedetti F, Viola S, Martini A . Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr. 1996; 128(2):275-8. DOI: 10.1016/s0022-3476(96)70408-0. View

14.

Ostensen M, Hoyeraal H, Kass E . Tolerance of cyclosporine A in children with refractory juvenile rheumatoid arthritis. J Rheumatol. 1988; 15(10):1536-8. View

15.

Behrens E, Beukelman T, Gallo L, Spangler J, Rosenkranz M, Arkachaisri T . Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR). J Rheumatol. 2007; 35(2):343-8. View

16.

Yokota S, Imagawa T, Mori M, Miyamae T, Takei S, Iwata N . Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan. Ann Rheum Dis. 2012; 72(4):627-8. DOI: 10.1136/annrheumdis-2012-202310. View

17.

Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B . Anakinra for systemic juvenile arthritis: the Rocky Mountain experience. J Clin Rheumatol. 2009; 15(4):161-4. DOI: 10.1097/RHU.0b013e3181a4f459. View

18.

Papsdorf V, Horneff G . Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis. Rheumatology (Oxford). 2010; 50(1):214-21. DOI: 10.1093/rheumatology/keq292. View

19.

Beukelman T, Patkar N, Saag K, Tolleson-Rinehart S, Cron R, Morgan DeWitt E . 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011; 63(4):465-82. PMC: 3222233. DOI: 10.1002/acr.20460. View

20.

Ohlsson V, Baildam E, Foster H, Jandial S, Pain C, Strike H . Anakinra treatment for systemic onset juvenile idiopathic arthritis (SOJIA). Rheumatology (Oxford). 2008; 47(4):555-6. DOI: 10.1093/rheumatology/ken030. View